- Home
- RNST vs PCVX Comparison
RNST vs PCVX Comparison
Compare RNST & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNST
- PCVX
- Stock Information
- Founded
- RNST 1904
- PCVX 2013
- Country
- RNST United States
- PCVX United States
- Employees
- RNST N/A
- PCVX N/A
- Industry
- RNST Major Banks
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- RNST Finance
- PCVX Health Care
- Exchange
- RNST Nasdaq
- PCVX Nasdaq
- Market Cap
- RNST 3.7B
- PCVX 6.0B
- IPO Year
- RNST N/A
- PCVX 2020
- Fundamental
- Price
- RNST $34.62
- PCVX $49.03
- Analyst Decision
- RNST Strong Buy
- PCVX Strong Buy
- Analyst Count
- RNST 6
- PCVX 7
- Target Price
- RNST $43.17
- PCVX $101.67
- AVG Volume (30 Days)
- RNST 554.7K
- PCVX 1.4M
- Earning Date
- RNST 10-28-2025
- PCVX 11-04-2025
- Dividend Yield
- RNST 2.66%
- PCVX N/A
- EPS Growth
- RNST N/A
- PCVX N/A
- EPS
- RNST 1.84
- PCVX N/A
- Revenue
- RNST $775,309,000.00
- PCVX N/A
- Revenue This Year
- RNST $43.22
- PCVX N/A
- Revenue Next Year
- RNST $12.94
- PCVX N/A
- P/E Ratio
- RNST $18.87
- PCVX N/A
- Revenue Growth
- RNST 13.04
- PCVX N/A
- 52 Week Low
- RNST $26.97
- PCVX $27.66
- 52 Week High
- RNST $40.40
- PCVX $98.17
- Technical
- Relative Strength Index (RSI)
- RNST 46.48
- PCVX 69.14
- Support Level
- RNST $34.45
- PCVX $40.14
- Resistance Level
- RNST $35.48
- PCVX $45.90
- Average True Range (ATR)
- RNST 0.84
- PCVX 2.30
- MACD
- RNST 0.19
- PCVX 0.26
- Stochastic Oscillator
- RNST 61.51
- PCVX 91.15
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.